Alterations in thyroid gland function result from the action of stimulating or blocking autoantibodies on cell membrane receptors ... a result of a mother with antibodies due to AITD.

This activity is designed for Clinical Laboratorians and other Healthcare Professionals interested in the management of patients with thyroid disease. Academic content will focus on the role(s) of TSH ...

TH receptors are nuclear transcription factors ... by investigators at the 8 th International Workshop on Resistance to Thyroid Hormone... Recent discoveries of genetic defects that reduce the ...

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor ... in patients with chronic thyroid eye disease (TED).

Hyperthyroidism is an autoimmune disorder caused by the thyroid stimulating antibody (TSI), active against the thyroid-stimulating hormone (TSH) receptor, which stimulates the gland to synthesize and ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

Topline data were announced from the phase 3 THRIVE-2 study evaluating veligrotug in patients with chronic thyroid eye ...

Sacituzumab govitecan is under clinical development by Gilead Sciences and currently in Phase II for Anaplastic Thyroid Cancer.